About Diapath
Diapath is a Healthcare company based in Martinengo (Italy) founded in 1997, and was acquired by StatLab in August 2024. Company focused on developing instruments and equipment for anatomic pathology in medical labs, hospitals, and research centers. Its chief executive, as recorded, is Vladimiro Bergamini. Diapath offers products and services including Histology Instruments and Reagents. Its legal entity is Diapath S.p.A.
Company details
Diapath was founded in 1997 in Martinengo, Italy, with a focus on the anatomic pathology sector. Instruments and equipment are developed by the company to support diagnostic processes. Solutions are provided to medical laboratories, hospitals, and research centers across various regions. Operations center on innovation in pathology tools, ensuring compatibility with standard lab workflows. The company is led by CEO Vladimiro Bergamini.
Products & Services of Diapath
Diapath offers a comprehensive portfolio of products and services, including Histology Instruments and Reagents.
Instruments for tissue processing and staining are supplied to facilitate anatomic pathology workflows.
Reagents for fixation, staining, and other processes are provided to support histology and cytology applications.
Apps and channels of Diapath
its YouTube channel DiapathCom has 442 subscribers and 30 videos.
Videos from Diapath
The most watched videos on Diapath's YouTube channel, DiapathCom (442 subscribers). Click a video to play it here.
More on DiapathCom.
Funding Insights of Diapath
- Total Rounds 4
- Last Round Grant — $55,679
- First Round $56,002
(May 2019)
- Investors Count 2
All 4 funding rounds of Diapath with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2022 | $55,679 | Grant | – | – | |
| Apr 2020 | $2.16M | Grant | – | – | |
| Aug 2019 | $55,104 | Grant | – | – | |
| May 2019 | $56,002 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Diapath
Diapath has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include StatLab, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Consumable supplies for histology, cytology, and immunohistochemistry are developed. | 1976 | statlab.com | Mckinney, United States |
Investor details for Diapath
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Diapath
1 people are tracked at Diapath (1 in leadership).
| Name | Role | Group |
|---|---|---|
Vladimiro Bergamini | CEO | Leadership |
Complete people profiles for Diapath
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Diapath
4 dated milestones of Diapath across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Diapath is founded.
- Funding First funding round of $56K.
- Funding Latest funding round, Grant, of $56K.
- Exit Acquired by StatLab.
Web traffic of Diapath
The website of Diapath (diapath.com) receives about 6.5K visits a month.
- Monthly visits6.5K
▼ 9% vs previous month
Websites whose visitors overlap most with Diapath. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bio-optica.it | 100% | #1,495,482 | View details | ||
nsh.org | nsh.org | 82% | #1,184,064 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Diapath
Diapath was founded in 1997 and raised its 1st funding round 22 years after it was founded.
Diapath is headquartered in Martinengo, Italy. It is registered at Martinengo, Lombardia, Italy.
Vladimiro Bergamini is the CEO of Diapath, as recorded in our data.
Diapath was founded in 1997 in Martinengo, Italy, with a focus on the anatomic pathology sector. Instruments and equipment are developed by the company to support diagnostic processes. Solutions are provided to medical laboratories, hospitals, and research centers across various regions. Operations center on innovation in pathology tools, ensuring compatibility with standard lab workflows. The company is led by CEO Vladimiro Bergamini.
Diapath offers Histology Instruments and Reagents.
Diapath has 3 investors. Key investors include StatLab, European Union, and EIC Fund.
Diapath operates through Diapath S.P.A..
Yes. Diapath was acquired by StatLab in August 2024.